loading
Precedente Chiudi:
$184.52
Aprire:
$184.44
Volume 24 ore:
24,449
Relative Volume:
0.11
Capitalizzazione di mercato:
$3.65B
Reddito:
$152.42M
Utile/perdita netta:
$45.24M
Rapporto P/E:
74.33
EPS:
2.51
Flusso di cassa netto:
$6.97M
1 W Prestazione:
+1.01%
1M Prestazione:
+5.64%
6M Prestazione:
+70.33%
1 anno Prestazione:
+70.41%
Intervallo 1D:
Value
$184.44
$188.77
Intervallo di 1 settimana:
Value
$182.87
$194.44
Portata 52W:
Value
$93.58
$194.44

Ligand Pharmaceuticals Inc Stock (LGND) Company Profile

Name
Nome
Ligand Pharmaceuticals Inc
Name
Telefono
858-550-7500
Name
Indirizzo
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
Name
Dipendente
68
Name
Cinguettio
@Ligand_LGND
Name
Prossima data di guadagno
2025-02-18
Name
Ultimi documenti SEC
Name
LGND's Discussions on Twitter

Confronta LGND con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
LGND
Ligand Pharmaceuticals Inc
186.50 3.60B 152.42M 45.24M 6.97M 2.51
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
420.16 106.97B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
659.01 68.62B 14.25B 4.58B 3.56B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
445.41 63.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
804.06 50.61B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.27 35.29B 398.11M -1.03B -868.57M -5.7032

Ligand Pharmaceuticals Inc Stock (LGND) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-10 Iniziato Stifel Buy
2024-10-03 Iniziato Oppenheimer Outperform
2024-07-30 Iniziato RBC Capital Mkts Outperform
2021-04-14 Ripresa Stephens Overweight
2021-02-04 Reiterato H.C. Wainwright Buy
2020-10-06 Iniziato Barclays Overweight
2020-03-24 Downgrade Argus Buy → Hold
2020-03-10 Iniziato Guggenheim Neutral
2020-02-06 Iniziato The Benchmark Company Buy
2019-09-19 Aggiornamento Barclays Equal Weight → Overweight
2019-06-11 Iniziato Barclays Equal Weight
2019-05-03 Reiterato H.C. Wainwright Buy
2019-03-06 Reiterato H.C. Wainwright Buy
2018-10-29 Aggiornamento ROTH Capital Neutral → Buy
2018-10-02 Reiterato H.C. Wainwright Buy
2018-09-11 Reiterato Argus Buy
2018-08-17 Iniziato Goldman Neutral
2018-08-08 Downgrade ROTH Capital Buy → Neutral
2018-06-21 Iniziato Argus Buy
2017-12-27 Reiterato H.C. Wainwright Buy
2017-09-05 Ripresa H.C. Wainwright Buy
2016-10-05 Reiterato H.C. Wainwright Buy
2016-08-05 Downgrade Deutsche Bank Hold → Sell
2016-03-11 Iniziato Sidoti Buy
2016-03-03 Iniziato H.C. Wainwright Buy
Mostra tutto

Ligand Pharmaceuticals Inc Borsa (LGND) Ultime notizie

pulisher
07:42 AM

Intraday pattern recognizer results for Ligand Pharmaceuticals IncorporatedWeekly Loss Report & Precise Swing Trade Entry Alerts - newser.com

07:42 AM
pulisher
05:49 AM

Ligand Pharmaceuticals (LGND) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

05:49 AM
pulisher
05:07 AM

Will Ligand Pharmaceuticals Incorporated outperform the marketJuly 2025 Retail & Weekly High Return Stock Opportunities - newser.com

05:07 AM
pulisher
04:33 AM

Will Ligand Pharmaceuticals Incorporated (LGDN) stock announce a stock splitWeekly Profit Report & Community Verified Trade Signals - newser.com

04:33 AM
pulisher
04:05 AM

Short interest data insights for Ligand Pharmaceuticals IncorporatedMarket Performance Report & Growth Focused Investment Plans - newser.com

04:05 AM
pulisher
02:17 AM

What institutional flow reveals about Ligand Pharmaceuticals IncorporatedChart Signals & High Conviction Buy Zone Picks - newser.com

02:17 AM
pulisher
Oct 29, 2025

Is Ligand Pharmaceuticals Incorporated forming a reversal patternMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Ligand Pharmaceuticals IncorporatedEquity Right (LGNZZ) Price Target Decreased by 44.49% to 0.08 - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Ligand Pharmaceuticals Reaches Analyst Target Price - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Is Ligand Pharmaceuticals Incorporated (LGDN) stock attractive post correctionStock Surge & Free High Accuracy Swing Entry Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

What catalysts could drive Ligand Pharmaceuticals Incorporated stock higherPortfolio Value Report & Low Risk High Win Rate Stock Picks - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Can Ligand Pharmaceuticals Incorporated stock sustain market leadership2025 Market Overview & Weekly High Return Opportunities - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

What analyst consensus says on Ligand Pharmaceuticals Incorporated stockWeekly Risk Summary & Free Daily Entry Point Trade Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Can technical indicators confirm Ligand Pharmaceuticals Incorporated’s reversalQuarterly Market Review & Community Consensus Trade Signals - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Why Ligand Pharmaceuticals Incorporated stock is a value investor pickJuly 2025 Chart Watch & Real-Time Stock Entry Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

How to use Fibonacci retracement on Ligand Pharmaceuticals IncorporatedQuarterly Profit Review & Verified Momentum Watchlists - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Technical signs of recovery in Ligand Pharmaceuticals IncorporatedPortfolio Update Summary & Verified High Yield Trade Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Ligand Pharmaceuticals Incorporated reversing from oversold territoryStop Loss & Intraday High Probability Setup Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Does Ligand Pharmaceuticals Incorporated show high probability of reboundJuly 2025 Review & Weekly High Potential Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Published on: 2025-10-28 01:03:19 - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How Ligand Pharmaceuticals Incorporated (LGDN) stock compares with market leadersCPI Data & Daily Oversold Bounce Ideas - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Analyzing drawdowns of Ligand Pharmaceuticals Incorporated with statistical tools2025 Macro Impact & Low Risk Entry Point Tips - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Ligand Pharmaceuticals Incorporated stock daily chart insightsWeekly Profit Report & Community Driven Trade Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Price action breakdown for Ligand Pharmaceuticals IncorporatedJuly 2025 Summary & Daily Stock Trend Reports - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Chart overlay techniques for tracking Ligand Pharmaceuticals IncorporatedWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com

Oct 27, 2025

Ligand Pharmaceuticals Inc Azioni (LGND) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.19
price up icon 1.40%
$28.54
price down icon 1.36%
$94.12
price up icon 4.36%
$104.84
price up icon 1.54%
biotechnology ONC
$309.11
price down icon 1.33%
$187.13
price up icon 12.09%
Capitalizzazione:     |  Volume (24 ore):